Combining SARS-CoV-2 Proofreading Exonuclease and RNA-Dependent RNA Polymerase Inhibitors as a Strategy to Combat COVID-19: A High-Throughput in silico Screening
Unique-regions SARS Cov2 sequencing and any infectious/other disease screening (Provisional Patent Application Number - 202021023223; miBiome)
Low-cost NGS for SARS Cov2 and any infectious/other disease screening (Provisional Patent Application Number - 202041030440; University of Hyderabad & miBiome)
Composition and method for detection of multiple drug resistance in tuberculosis by multiplex short-amplicon based targeted NGS (tNGS) using ribonucleotide bases in the primers to increase target specificity
